Annual EBITDA
-$169.40 M
-$62.19 M-58.01%
31 December 2023
Summary:
Bicycle Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$169.40 million, with the most recent change of -$62.19 million (-58.01%) on 31 December 2023. During the last 3 years, it has fallen by -$119.40 million (-238.80%). BCYC annual EBITDA is now -966.67% below its all-time high of -$15.88 million, reached on 31 December 2017.BCYC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$52.05 M
-$14.81 M-39.78%
30 September 2024
Summary:
Bicycle Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$52.05 million, with the most recent change of -$14.81 million (-39.78%) on 30 September 2024. Over the past year, it has dropped by -$6.92 million (-15.34%). BCYC quarterly EBITDA is now -1785.01% below its all-time high of -$2.76 million, reached on 31 March 2018.BCYC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$160.02 M
-$6.92 M-4.52%
30 September 2024
Summary:
Bicycle Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$160.02 million, with the most recent change of -$6.92 million (-4.52%) on 30 September 2024. Over the past year, it has dropped by -$8.74 million (-5.78%). BCYC TTM EBITDA is now -5695.62% below its all-time high of -$2.76 million, reached on 31 March 2018.BCYC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCYC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.0% | -15.3% | -5.8% |
| 3 y3 years | -238.8% | -273.5% | -153.1% |
| 5 y5 years | -686.8% | -419.9% | -457.5% |
BCYC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -238.8% | at low | -273.5% | at low | -153.1% | +5.5% |
| 5 y | 5 years | -686.8% | at low | -474.9% | at low | -457.5% | +5.5% |
| alltime | all time | -966.7% | at low | -1785.0% | at low | -5695.6% | +5.5% |
Bicycle Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$52.05 M(+39.8%) | -$160.02 M(+4.5%) |
| June 2024 | - | -$37.23 M(+52.4%) | -$153.09 M(-2.2%) |
| Mar 2024 | - | -$24.43 M(-47.2%) | -$156.51 M(-7.6%) |
| Dec 2023 | -$169.40 M(+58.0%) | -$46.30 M(+2.6%) | -$169.40 M(+12.0%) |
| Sept 2023 | - | -$45.12 M(+11.0%) | -$151.28 M(+14.0%) |
| June 2023 | - | -$40.65 M(+8.9%) | -$132.66 M(+12.6%) |
| Mar 2023 | - | -$37.32 M(+32.4%) | -$117.78 M(+9.9%) |
| Dec 2022 | -$107.21 M(+67.3%) | -$28.19 M(+6.3%) | -$107.21 M(+11.0%) |
| Sept 2022 | - | -$26.50 M(+2.8%) | -$96.58 M(+15.0%) |
| June 2022 | - | -$25.77 M(-3.6%) | -$84.01 M(+11.8%) |
| Mar 2022 | - | -$26.74 M(+52.3%) | -$75.15 M(+17.3%) |
| Dec 2021 | -$64.09 M | -$17.56 M(+26.0%) | -$64.09 M(+1.4%) |
| Sept 2021 | - | -$13.93 M(-17.6%) | -$63.23 M(+6.1%) |
| June 2021 | - | -$16.91 M(+7.8%) | -$59.57 M(+9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$15.68 M(-6.1%) | -$54.56 M(+9.1%) |
| Dec 2020 | -$50.00 M(+67.2%) | -$16.70 M(+62.5%) | -$50.00 M(+18.1%) |
| Sept 2020 | - | -$10.27 M(-13.7%) | -$42.35 M(+0.6%) |
| June 2020 | - | -$11.90 M(+7.0%) | -$42.09 M(+10.9%) |
| Mar 2020 | - | -$11.13 M(+22.9%) | -$37.95 M(+26.9%) |
| Dec 2019 | -$29.90 M(+38.9%) | -$9.05 M(-9.6%) | -$29.90 M(+4.2%) |
| Sept 2019 | - | -$10.01 M(+29.0%) | -$28.70 M(+15.4%) |
| June 2019 | - | -$7.76 M(+151.8%) | -$24.88 M(+13.7%) |
| Mar 2019 | - | -$3.08 M(-60.8%) | -$21.89 M(+1.5%) |
| Dec 2018 | -$21.53 M(+35.6%) | -$7.85 M(+27.0%) | -$21.57 M(+57.3%) |
| Sept 2018 | - | -$6.18 M(+29.7%) | -$13.71 M(+82.1%) |
| June 2018 | - | -$4.77 M(+72.7%) | -$7.53 M(+172.7%) |
| Mar 2018 | - | -$2.76 M | -$2.76 M |
| Dec 2017 | -$15.88 M | - | - |
FAQ
- What is Bicycle Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual EBITDA year-on-year change?
- What is Bicycle Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly EBITDA year-on-year change?
- What is Bicycle Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Bicycle Therapeutics?
- What is Bicycle Therapeutics TTM EBITDA year-on-year change?
What is Bicycle Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BCYC is -$169.40 M
What is the all time high annual EBITDA for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$15.88 M
What is Bicycle Therapeutics annual EBITDA year-on-year change?
Over the past year, BCYC annual earnings before interest, taxes, depreciation & amortization has changed by -$62.19 M (-58.01%)
What is Bicycle Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BCYC is -$52.05 M
What is the all time high quarterly EBITDA for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2.76 M
What is Bicycle Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BCYC quarterly earnings before interest, taxes, depreciation & amortization has changed by -$6.92 M (-15.34%)
What is Bicycle Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BCYC is -$160.02 M
What is the all time high TTM EBITDA for Bicycle Therapeutics?
Bicycle Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.76 M
What is Bicycle Therapeutics TTM EBITDA year-on-year change?
Over the past year, BCYC TTM earnings before interest, taxes, depreciation & amortization has changed by -$8.74 M (-5.78%)